Gabriel Ling - Nov 22, 2024 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Gabriel Ling
Stock symbol
TOI
Transactions as of
Nov 22, 2024
Transactions value $
$0
Form type
4
Date filed
11/25/2024, 04:20 PM
Previous filing
Dec 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Award $0 +40K +57.92% $0.00 109K Nov 22, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in full on TOI, Inc.'s 2025 annual shareholder meeting date, subject to continued service with the Company through such vesting date.